$CIIX CBD Medical Marijuana China Clinical trials and research: CIIX will further study the efficacy of CBD oil for the treatment of epilepsy and Alzheimer?s disease. Besides, the Company will invest in CBD drug R&D enterprises with the goal of developing various CBD drugs that have positive efficacy in combating Epilepsy and Alzheimer?s disease. The application period for new drugs of this type in China is 2 to 4 years, which is much shorter compared to that of FDA. Our goal is to be the first company in China to use CBD oil to help mitigate the suffering of patients with Epilepsy and Alzheimers disease.
Nothing I say, post, or do should ever be considered financial advice. I may be holding a long, short or no position. I am NOT or NEVER have I been compensated to post on here or anywhere and all my posts are for entertainment purposes only.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.